AzTrials
AzTrials

DepressionMINDUP-PAKNCT07468994

Effect of the MindUP Program on Depression, Anxiety, and Stress in Pakistani Orphan Adolescents

A study testing MindUP Program in people with Depression and Anxiety, run by Quaid-e-Azam University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effectiveness of the MindUP mindfulness-based program in reducing depression, anxiety, and stress among orphan adolescents in Pakistan. Adolescents living in orphan care institutions often experience significant psychological distress due to early life adversity, loss of parental support, and… Read more about this study

Who is it for?
Ages 11 to 16 years, men onlyHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety, Stress
What is being tested?
MindUP Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
1 sitePakistan
Study dates
8 Jun 2024to 28 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 16 years
  • Men only
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Male adolescents aged 11-16 years.
  • Residing in an orphan care institution.
  • Currently enrolled in school (grades 7-8).
  • Able to understand and participate in the MindUP program sessions.
  • Provided assent to participate and permission obtained from the institutional authorities/guardians.

Who cannot join

  • Adolescents currently receiving psychological or psychiatric treatment.
  • Adolescents with severe cognitive or developmental disorders that would interfere with participation in the intervention.
  • Adolescents who did not complete baseline assessments or were absent for most intervention sessions.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Aghosh Alkhidmat Foundation College Murree

    Islamabad, Islamabad, 44000

Other trials in Pakistan

About this study

Official title: Does MindUP Work With Pakistani Orphan Adolescents? Assessing Its Efficacy in Lowering Depression, Anxiety and Stress

This study evaluates the effectiveness of the MindUP mindfulness-based program in reducing depression, anxiety, and stress among orphan adolescents in Pakistan. Adolescents living in orphan care institutions often experience significant psychological distress due to early life adversity, loss of parental support, and institutional living conditions.

A school-based quasi-experimental design was used to examine whether participation in the MindUP program improves mental health outcomes among orphan adolescents. Participants were adolescents residing in orphanages in Pakistan who were assigned to either an intervention group receiving the MindUP program or a comparison group receiving routine institutional activities.

Read more

The MindUP intervention consisted of structured mindfulness and social-emotional learning sessions designed to enhance emotional regulation, attention, and psychological well-being. The program was delivered over several weeks by trained facilitators.

Psychological outcomes including depression, anxiety, and stress were measured using standardized self-report scales before and after the intervention. The study aims to determine whether the MindUP program is effective in improving mental health among orphan adolescents in low-resource institutional settings.

Being tested
MindUP Program
Keywords
MindUP, Mindfulness Intervention, Orphan Adolescents, Mental Health, Pakistan, School based intervention
Medical subject headings
Depression, Anxiety Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MindUP ProgramBehavioural

    MindUP is a mindfulness-based social and emotional learning program that teaches participants skills related to mindful awareness, emotional regulation, attention, and stress management through structured exercises and activities.

Study groups in NCT07468994
Study groupRoleWhat they receive
MindUP Intervention GroupExperimentalParticipants in this group received the MindUP mindfulness-based intervention program designed to improve emotional regulation, attention, and psychological well-being. The program consisted of structured sessions focusing on mindfulness practices, social-emotional learning, and awareness exercises delivered over several weeks.
Receives: Behavioral: MindUP Program
Control GroupNo interventionParticipants in this group continued their routine institutional activities and did not receive the MindUP intervention during the study period. Psychological outcomes were assessed at the same time points as the intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depression Symptoms (DASS-21 Depression Subscale)

    Depression symptoms were measured using the Depression subscale of the Depression Anxiety Stress Scales (DASS-21). Higher scores indicate greater levels of depressive symptoms. Changes from baseline to post-intervention were assessed to evaluate the effectiveness of the MindUP program.

    Measured: Baseline to Post-Intervention (15 weeks)

Secondary outcomes (2)
  1. Change in Stress Levels (DASS-21 Stress Subscale)

    Measured: Baseline to Post-Intervention (15 weeks)

  2. Change in Anxiety Symptoms (DASS-21 Anxiety Subscale)

    Measured: Baseline to Post-Intervention (15 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2026
  2. Study start8 Jun 2024
  3. Primary completion21 Sep 2024
  4. Study completion28 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Participants were assigned to two parallel groups: an intervention group receiving the MindUP mindfulness-based program and a comparison group receiving routine institutional activities. Outcomes were measured at baseline and post-intervention to assess changes in depression, anxiety, and stress.
Masking
None (open label)
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07468994
Sponsor's protocol ID
NIP-MINDUP-2026
Acronym
MINDUP-PAK
Status last verified
Mar 2026
First submitted
9 Mar 2026
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MindUP Program in people with Depression and Anxiety, run by Quaid-e-Azam University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Depression Symptoms (DASS-21 Depression Subscale) (time frame: Baseline to Post-Intervention (15 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in